Revolution Medicines

Revolution Medicines

Associate Principal Statistical Analyst

Redwood City, California, United States · Principal · Full-time

Sponsorship not specified$10k-$14kDetected 1 day ago
ComplianceVendor ManagementRecruitingCustomer SupportClinical TrialsFDA RegulatoryLeadershipCommunicationMentoringPublic SpeakingGxP

About the role

  • Provide technical oversight of statistical programming resources including contractors and CROs.
  • Provide mentorship to future leaders to help learn and execute on RevMed core values.
  • Ensure quality and timely delivery of analysis for statistical programming deliverables.

Responsibilities

  • Programming support for deliverables, such as Dose Committee meetings, Investigator Brochures, publications/presentations, US, and ex-US regulatory submissions.
  • Direct statistical programming experience for early or late-phase clinical trials to support production/verification of analysis datasets, tables, listings, and figures.

Requirements

  • Demonstrated ability to multi-task, prioritize options, anticipate challenges, and execute goals as a member of an interdisciplinary team is extremely important.
  • Proficiency in regulatory standards and compliance regulations including CDISC compliance (SDTM, ADaM, define.xml, Reviewer's Guides, etc.).
  • Based on company needs, this position may be required to lead an early Phase or late phase study or program.

Skills

  • 10-14 years of Statistical Programming experience in biotechnology or pharmaceutical industry.
  • BS/BA degree or other suitable qualification with relevance to the field.
  • Early or late-stage oncology clinical trials.
  • A demonstrable record of strong leadership and teamwork.
  • #LI-DN1 #LI-Hybrid
  • The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below.

Compensation

  • $164,000 - $205,000 USD
  • Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process.

Company info

  • Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
  • The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
  • The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
  • As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Apply directly at Revolution Medicines →Create a free account for alerts like thisView Revolution Medicines immigration profile

This listing is sourced directly from Revolution Medicines's careers page and normalized into a canonical job model.